Biosimilars and Patients: Addressing Safety, Cost, Anxiety
Physicians can respond to pushback from patients on switching to a biosimilar by offering resources and discussing options for both biosimilar and reference drugs.
Medscape Medical News
source https://www.medscape.com/viewarticle/990276?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/990276?src=rss
Comments
Post a Comment